Amgen Price Target Hiked to $370.04 Amid 5% Downside Implied

Amgen Inc.'s stock price target has been revised upwards by analysts. The average forecast now stands at $370.04, up from a previous estimate of $357.48. This implies around 5% potential downside for investors based on the company's closing price on August 4.

The price range among forecasts varies widely, spanning from $220 to $452 per share. Despite this, all analysts surveyed agree that the stock is worth buying, with a consensus rating of 'Buy' across 35 covering experts.